Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen.
about
On the front lines of Lassa feverPathogenesis of Lassa feverAdvanced vaccine candidates for Lassa feverMapping the zoonotic niche of Lassa fever in AfricaThe impact of human conflict on the genetics of Mastomys natalensis and Lassa virus in West AfricaNew Hosts of The Lassa VirusRisk maps of Lassa fever in West AfricaPrevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional studyLassa fever: epidemiology, clinical features, and social consequences.Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections.Lassa serology in natural populations of rodents and horizontal transmissionArenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa feverSequence variability and geographic distribution of Lassa virus, Sierra Leone.Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to manMastomys natalensis and Lassa fever, West Africa.A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunityMurine infection with lymphocytic choriomeningitis virus following gastric inoculation.Lassa virus.Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers.Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse modelHemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.Rat-atouille: A Mixed Method Study to Characterize Rodent Hunting and Consumption in the Context of Lassa FeverVaccine platforms to control Lassa fever.Laboratory Diagnosis of Lassa FeverDetection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use.Seroepidemiological study reveals regional co-occurrence of Lassa- and Hantavirus antibodies in Upper Guinea, West Africa.Diagnostics for Lassa Fever: Detecting Host Antibody Responses.Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.Lassa Fever 2016 Outbreak in Plateau State, Nigeria-The Changing Epidemiology and Clinical Presentation
P2860
Q24599583-F70EA4D6-7173-4B6C-B15E-1274412D9302Q24613450-8C80C31D-E290-44A7-AA14-81C715BE7C73Q26823627-FAA9B569-F518-496F-9514-883AA49C5D6CQ27001682-2F194A37-0CAE-4EA8-A0CA-BADC6156BC90Q27302926-A49D7686-42DD-4E75-B938-A6FE3FDD99CBQ28833686-37CE4576-9178-4A3C-9C4F-FEB78F3396D2Q33414102-9D838897-96FF-4B56-8250-706989FFE06EQ33516227-D2A393F7-CDA7-4BFD-BF45-38D58C605BA4Q33822092-B5FC7A87-E1D2-4D4E-8FA4-9217CD4364F6Q33887328-03ECFE6C-189B-43A4-9963-C70202C75D49Q34222970-11DC51F0-9915-41A1-B130-C0FD02A575BEQ34467311-678B2050-EDCC-4ED4-90A1-1AB24DA3561EQ34888593-23A06A3D-7B8C-46E0-B03B-732ABF002196Q35229675-75FCF875-61E5-4C36-B680-B86FC9E46030Q35248863-4BF9EE04-D6A4-4FFB-8B71-A41CEC8A1A59Q35793687-8F89A5B2-E2D0-4F91-B15B-A4AA653541E7Q35842756-09FE0F3D-54B6-4DA6-BFC0-C650E2290567Q35871026-55D5A396-CF93-4D88-85C4-6EFCC0A54558Q35919691-60E06030-F5FA-48B8-AA6B-B93533CDB547Q36095179-F128F318-96A3-402E-800E-256C7B8306FBQ36395853-0C180511-0253-4329-B4C7-8F15F39A1762Q36581311-321854D4-9BA8-41DF-A61D-7DFBD3370180Q36681272-E7478CFB-30FB-4A1D-8233-67769F11642BQ37201592-5D35A546-F086-4518-8A39-D3F2C7BDF5CBQ38823264-9F625F50-AE74-4D16-B6D2-4ECE22DFB2ECQ39238911-98509764-D449-42A4-82E7-1E84F1056B24Q39517640-CEA6E4B2-CAF6-4DA8-8CC9-32420A2DE958Q40262453-42895DD0-9E8E-48A7-9E58-2B0697212B51Q41922464-294B1015-6341-447D-9336-5E33B1DD555BQ47244680-E641C0AD-F7DC-4E26-908B-3E402C238060Q58694237-A2C4D9C7-732A-4538-9F5F-2E9272D60DB7
P2860
Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Lassa virus activity in Guinea ...... ssay with recombinant antigen.
@en
Lassa virus activity in Guinea ...... ssay with recombinant antigen.
@nl
type
label
Lassa virus activity in Guinea ...... ssay with recombinant antigen.
@en
Lassa virus activity in Guinea ...... ssay with recombinant antigen.
@nl
prefLabel
Lassa virus activity in Guinea ...... ssay with recombinant antigen.
@en
Lassa virus activity in Guinea ...... ssay with recombinant antigen.
@nl
P2093
P356
P1476
Lassa virus activity in Guinea ...... ssay with recombinant antigen.
@en
P2093
Lukashevich IS
P2860
P304
P356
10.1002/JMV.1890400308
P577
1993-07-01T00:00:00Z